Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Dvorak, H. F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J. Clin. Oncol. 20, 4368–4380 (2002).
2. Ferrara, N. Vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 29, 789–791 (2009).
3. Sloan, B. & Scheinfeld, N. S. Pazopanib, a VEGF receptor tyrosine kinase inhibitor for cancer therapy. Curr. Opin. Investig. Drugs. 9, 1324–1335 (2008).
4. Sullivan, L. A. & Brekken, R. A. The VEGF family in cancer and antibody-based strategies for their inhibition. MAbs. 2, 165–175 (2010).
5. Niraula, S., Amir, E., Vera-Badillo, F., Seruga, B., Ocana, A. & Tannock, I. F. Risk of incremental toxicities and associated costs of new anticancer drugs: a meta-analysis. J. Clin. Oncol. 32, 3634–3642 (2014).
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献